Ads
related to: what is daratumumab prescribed for in adults symptoms pictures- DARZALEX® Side Effects
Find Information About Side Effects
Patients May Experience
- Cost Support Options
Learn About Potential Cost Support
Options Through Janssen CarePath
- Read Patient Stories
Learn About the Treatment Journey
From Real Patients & Caregivers
- Sign Up for Support
Register With Janssen CarePath to
Receive Support Program Information
- Questions for Your Doctor
Find a List Of Questions for You to
Ask Your Healthcare Provider
- Preparing For Treatment
Watch a Video About What to Expect
Before, During, & After Treatment
- DARZALEX® Side Effects
careinfo.mayoclinic.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Daratumumab, sold under the brand name Darzalex among others, is an anti-cancer monoclonal antibody medication. It binds to CD38 , [ 7 ] which is overexpressed in multiple myeloma cells. [ 8 ]
cryopyrin-associated periodic syndrome, Yao's Syndrome, Adult Onset Still's Disease: Cantuzumab mertansine [42] mab: humanized: CanAg (a glycoform of MUC1) colorectal cancer etc. Cantuzumab ravtansine [42] mab: humanized: CanAg (a glycoform of MUC1) cancers Caplacizumab [44] Cablivi: sdAb: humanized: VWF: Y: thrombotic thrombocytopenic purpura ...
It was approved for use in the United States in May 2020. [2] [7] [8]Efficacy of daratumumab and hyaluronidase-fihji (monotherapy) was evaluated in the COLUMBA trial (NCT03277105), an open-label non-inferiority trial randomizing 263 participants to daratumumab and hyaluronidase-fihj and 259 to intravenous daratumumab (daratumumab IV). [2]
Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors.It is directed against the platelet-derived growth factor receptor alpha.
Older adults are prone to dehydration for many reasons. Learn how to identify the symptoms of dehydration in older adults based on how they look and feel.
Elranatamab is indicated for the treatment of adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. [8] [12]
Ads
related to: what is daratumumab prescribed for in adults symptoms pictures